Anti-epidermal growth factor receptor monoclonal antibody 225 up- regulates p27(KIP1) and induces G1 arrest in prostatic cancer cell line DU145

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3666-3669

  Peng, Ding ^a   Fan, Zhen ^a   Lu, Yang ^a   DeBlasio, Tony ^a   Scher, Howard ^a,b   Mendelsohn, John ^a,b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE H1; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTAMINE KINASE; RECEPTOR ANTIBODY; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MONOLAYER CULTURE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0029776415     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Boring, C C., Squires, T. S , and Tong, T. Cancer statistics. Cancer (Phila.). 43: 7-26, 1993.
2. Nabors, W., and Crawford, E. D. Metastatic prostate cancer hormonal treatment World J Urol., 8, 34-39, 1990.
3. Ware, J L. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev., 12: 287-301, 1993
4. Hofer, D R, Sherwood, E. R. Bromberg, W. D., Mendelsohn, J., and Lee, C Autonomous growth of androgen-independent human prostatic carcinoma cells, role of transforming growth factor α Cancer Res , 51: 2780-2785, 1991.
5. Fong, C. J., Sherwood, E. R , Mendelsohn, J., Lee, C., and Kozlowski, J. M Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor α. Cancer Res., 52: 5887-5892, 1992.
6. Scher, H , Sarkis, A., Reuter, V., Cohen, D , Netto, G , Petrylak, D., Lianes, P., Fuks, Z , Mendelsohn, J., and Cordon-Cardo, C Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor-α in the progression of prostatic neoplasms. Clin Cancer Res , 1: 545-550, 1995.
7. Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., and Mendelsohn, J Growth stimulation of A431 cells by EGF identification of high affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA, 80 1337-1341, 1983.
8. Gill, G N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., MacLeod, C L , and Mendelsohn, J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem., 259: 7755-7760, 1984
9. Van de Vijver, M , Kumar, R., and Mendelsohn, J. Ligand-induced activation of A431 cell EGF receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J Biol. Chem., 266: 7503-7508, 1991.
10. Mendelsohn, J. The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. Semin. Cancer Biol, 1: 339-344, 1990.
11. Grana, X , and Reddy, E. P. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11: 211-219, 1995.
12. Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation medicates ligand-induced A431 cell growth inhibition. J. Cell. Biol., 131 235-242, 1995
13. 1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody Oncogene, 12: 1996.
14. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
15. Muller, R. Transcriptional regulation during the mammalian cell cycle. Trends Genet., 11: 173-178, 1995.
16. Bookstein, R., Shew, J., Chen, P., Scull, P , and Lee, W. Suppression of tumorigenicity of human prostate carcinoma ceils by replacing a mutated Rb gene. Science (Washington DC), 247: 712-715, 1990.
17. Hannon, G. J., Demetrick, D., and Beach, D. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Dev., 7: 2378-2391, 1993.
18. Claudio, P. P., De Luca, A., Howard, C. M. Baldi, A , Firpo, E. J., Koff, A., Paggi, M G , and Giordano, A Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res., 56: 2003-2008, 1996.
19. KIP1 accumulation during the cell cycle Science (Washington DC), 271: 1861-1864, 1996.
20. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P R , Draetta, G. F , and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995